Tester Jason E. 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Jun 17, 2021
Insider Transaction Report
Form 4
Tester Jason E.
Director10% Owner
Transactions
- Award
Stock Option (right to buy)
2021-06-15+10,000→ 10,000 totalExercise: $35.26Exp: 2031-06-15→ Common Stock (10,000 underlying) - Award
Stock Option (right to buy)
2021-06-15+10,000→ 10,000 totalExercise: $35.26Exp: 2031-06-15→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2021 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
- [F2]Option granted in connection with the Reporting Person's service as a non-employee director as of the closing of the Company's initial public offering and continued service as of the Company's 2021 annual meeting of stockholders. The option is fully vested.